Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 26, 2023

BUY
$68.3 - $87.44 $16,665 - $21,335
244 Added 9.69%
2,763 $0
Q3 2022

Oct 31, 2022

SELL
$82.37 - $107.29 $66,060 - $86,046
-802 Reduced 24.15%
2,519 $208,000
Q2 2022

Jul 26, 2022

BUY
$86.5 - $128.27 $34,686 - $51,436
401 Added 13.73%
3,321 $316,000
Q1 2022

Apr 27, 2022

SELL
$101.96 - $128.34 $37,011 - $46,587
-363 Reduced 11.06%
2,920 $344,000
Q4 2021

Jan 31, 2022

SELL
$106.37 - $130.68 $987,964 - $1.21 Million
-9,288 Reduced 73.88%
3,283 $425,000
Q3 2021

Nov 03, 2021

BUY
$102.91 - $122.75 $1.29 Million - $1.54 Million
12,571 New
12,571 $1.42 Million
Q4 2020

Jan 28, 2021

SELL
$71.69 - $91.23 $1.76 Million - $2.24 Million
-24,513 Closed
0 $0
Q3 2020

Oct 29, 2020

BUY
$67.19 - $87.44 $67,660 - $88,052
1,007 Added 4.28%
24,513 $1.96 Million
Q2 2020

Jul 24, 2020

BUY
$57.54 - $76.95 $460,550 - $615,907
8,004 Added 51.63%
23,506 $1.63 Million
Q1 2020

Apr 29, 2020

BUY
$52.41 - $81.0 $258,748 - $399,897
4,937 Added 46.73%
15,502 $2.92 Million
Q4 2019

Jan 27, 2020

BUY
$71.7 - $82.09 $520,900 - $596,383
7,265 Added 220.15%
10,565 $2.47 Million
Q1 2019

Apr 30, 2019

SELL
$47.89 - $64.05 $574 - $768
-12 Reduced 0.36%
3,300 $631,000
Q4 2018

Feb 01, 2019

SELL
$46.41 - $56.94 $889,679 - $1.09 Million
-19,170 Reduced 85.27%
3,312 $507,000
Q3 2018

Nov 05, 2018

SELL
$45.7 - $58.03 $126,771 - $160,975
-2,774 Reduced 10.98%
22,482 $3.91 Million
Q2 2018

Jul 30, 2018

BUY
$42.45 - $51.3 $108,374 - $130,968
2,553 Added 11.25%
25,256 $3.68 Million
Q1 2018

May 02, 2018

BUY
$37.19 - $47.45 $844,324 - $1.08 Million
22,703 New
22,703 $3.17 Million
Q4 2017

Jan 31, 2018

SELL
$33.79 - $39.39 $43,893 - $51,167
-1,299 Closed
0 $0
Q3 2017

Oct 31, 2017

BUY
$36.29 - $38.83 $47,140 - $50,440
1,299
1,299 $142,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Dupont Capital Management Corp Portfolio

Follow Dupont Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Dupont Capital Management Corp with notifications on news.